CALCULATE YOUR SIP RETURNS

Stocks/Share Market - Angel One

Omkara ARC Secures Rs. 6,151 Crore IDBI Bank NPA Portfolio

Omkara ARC Secures Rs. 6,151 Crore IDBI Bank NPA Portfolio

5 August 2024

In a crucial auction, Omkara Asset Reconstruction Company (ARC) has emerged as the winning bidder to acquire non-performing assets (NPAs) worth Rs.6,151.16 crore from the Stressed Asset Stabilisation Fund (SASF) of the erstwhile Industrial Development Bank of India (IDBI), according to the reports. This sale translates to a recovery of 10.5% for IDBI Bank, positively …

Gautam Adani to Resign at 70, Plans to Hand Over Control to Family by 2030

Gautam Adani to Resign at 70, Plans to Hand Over Control to Family by 2030

5 August 2024

Gautam Adani, the 62-year-old chairman of Adani Group, has announced his intention to retire by the age of 70 and transfer control of his $213 billion empire to the next generation by the early 2030s. In an interview with media, Adani detailed his succession plan, emphasizing that his sons, Karan and Jeet, along with their …

Share Market Pre Open Updates – August 05, 2024

Share Market Pre Open Updates – August 05, 2024

5 August 2024

On August 2, 2024, the benchmark indices Nifty 50 was down 1.17% to close at 24,717, and Sensex was down 1.08% to close at 80,981. Top Gainers and Losers On the sectoral front, the Nifty Pharma and Healthcare Index ended in the green. Meanwhile, Nifty Realty, Auto, Metal, and IT were declining. The top gainers …

Suryoday Small Finance Bank Sees 30.5% YoY Surge in Net Interest Income in Q1 FY25

Suryoday Small Finance Bank Sees 30.5% YoY Surge in Net Interest Income in Q1 FY25

2 August 2024

Suryoday Small Finance Bank Limited has released its unaudited financial results for the quarter ended June 30, 2024. Financial Highlights Net interest income reached ₹293.2 crore in Q1 FY25, up from ₹224.7 crore in Q1 FY24, reflecting a year-on-year growth of 30.5%. Net total income was ₹363.4 crore in Q1 FY25, compared to ₹275.7 crore …

Le Travenues Technology Limited Reports 27% GTV Growth and 78% Profit Increase in Q1 FY25

Le Travenues Technology Limited Reports 27% GTV Growth and 78% Profit Increase in Q1 FY25

2 August 2024

On August 01, 2024, Le Travenues Technology Limited, known as India’s leading Online Travel Agency (OTA) for the Next Billion Users, released its financial results for the quarter ending June 30, 2024. Key Performance Highlights – Q1 FY25 In Q1 FY25, Le Travenues Technology Limited achieved significant growth across various financial metrics. The Gross Transaction …

Club Mahindra Partners with Lohono Stays for Exclusive Villas in Goa

Club Mahindra Partners with Lohono Stays for Exclusive Villas in Goa

2 August 2024

On August 2, 2024, Mahindra Holidays & Resorts India Limited (MHRIL) announced a significant enhancement to its Club Mahindra offerings through a strategic partnership with Lohono Stays, a leading name in serviced luxury villas. This collaboration marks a notable expansion of Club Mahindra’s presence in North Goa, a region renowned for its vibrant culture and …

Hindustan Zinc Reports Record Q1 Production of 263 kt and Revenue of  ₹8,130 Crore

Hindustan Zinc Reports Record Q1 Production of 263 kt and Revenue of ₹8,130 Crore

2 August 2024

On August 02, 2024, Hindustan Zinc Limited (HZL), a top global producer of zinc, lead, and silver, released its financial results for the first quarter ending June 30, 2024. In the first quarter, Hindustan Zinc achieved its highest-ever mined metal production at 263,000 tonnes (kt), a 2% increase from the previous year. However, it was …

Alembic Pharmaceuticals Secures USFDA Approval for Nelarabine Injection

Alembic Pharmaceuticals Secures USFDA Approval for Nelarabine Injection

2 August 2024

Alembic Pharmaceuticals Limited today announced a significant milestone with the US Food and Drug Administration’s (USFDA) final approval of its Abbreviated New Drug Application (ANDA) for Nelarabine Injection, 250 mg/50 mL (5 mg/mL). This single-dose vial formulation is therapeutically equivalent to Sandoz Inc.’s Arranon Injection. Nelarabine, a nucleoside metabolic inhibitor, is a critical treatment for …

Zydus Wellness Achieves Record Q1 Results with 20% Sales Growth

Zydus Wellness Achieves Record Q1 Results with 20% Sales Growth

2 August 2024

On August 2, 2024, Zydus Wellness Ltd. reported its highest-ever first-quarter net sales, which increased by 20% to ₹8,391 million compared to the same period last year. The company’s EBITDA grew by 33.3% year-over-year to ₹1,553 million. Net profit for the quarter rose by 33.8% to ₹1,477 million. Adjusted PAT, which excludes exceptional items and …

Black Box Secures ₹410 Crore for Digital Infrastructure Expansion

Black Box Secures ₹410 Crore for Digital Infrastructure Expansion

2 August 2024

On August 2, 2024, Black Box Limited announced to the stock exchanges that it has secured commitments totalling ₹410 crore through a preferential issue aimed at accelerating growth and expansion in the digital infrastructure sector. The Board of Directors approved the issuance of up to 98,32,123 fully convertible warrants, priced at ₹417 each, aggregating to …

Open Free Demat Account!

Join our 2 Cr+ happy customers

+91
Open Free Demat Account!
Join our 2 Cr+ happy customers